Lunsumio intravenous drip 30mg (Mosunetuzumab), from Chugai Pharmaceutical (YJ code: 4291476A2024, standard: 30mg 30mL bottle), is a bispecific antibody. It is used for relapsed or refractory follicular lymphoma after at least two prior systemic therapies, working by engaging T-cells to destroy CD20-expressing cancer cells.
Lunsumio intravenous drip 30mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).